Prostate Cancer
Clarity's Theranostic Prostate Cancer Trial Progresses at the Highest Dose Level Cohort
November 29, 2023
Can We Predict Skeletal Lesion on Bone Scan Based on Quantitative PSMA PET/CT Features?
November 29, 2023
Delphi consensus project on prostate-specific membrane antigen (PSMA)-targeted surgery-outcomes from an international multidisciplinary panel.
November 29, 2023
Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry.
November 29, 2023
Prostate cancer cell-derived exosomal IL-8 fosters immune evasion by disturbing glucolipid metabolism of CD8+ T cell.
November 29, 2023
Antitumor activity of AZD0754, a dnTGFβRII-armored, STEAP2-targeted CAR-T cell therapy, in prostate cancer.
November 29, 2023
SND1 binds to ERG and promotes tumor growth in genetic mouse models of prostate cancer.
November 28, 2023
Genome-wide association study of prostate-specific antigen levels in 392,522 men identifies new loci and improves cross-ancestry prediction.
November 28, 2023
Targeting DNA methylation and B7-H3 in RB1-deficient and neuroendocrine prostate cancer.
November 28, 2023
Direct costs of treating men with prostate cancer with High Intensity Focused Ultrasound.
November 28, 2023
DNA Damage Response and Mismatch Repair Gene Defects in Advanced and Metastatic Prostate Cancer.
November 28, 2023
Magnetic Resonance Perfusion Imaging of Prostate.
November 28, 2023
Combiner and HyperCombiner networks: Rules to combine multimodality MR images for prostate cancer localisation.
November 28, 2023
Targeting the αVβ3/ngr2 Pathway in Neuroendocrine Prostate Cancer
November 27, 2023